GlobeNewswire: Advanced Medical Isotope Corporation Contains the last 10 of 67 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T06:37:09ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2017/09/14/1121085/0/en/Advanced-Medical-Isotope-Corporation-ADMD-has-its-first-discussions-with-private-animal-consortiums-to-utilize-RadioGelT.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Corporation (ADMD) has its first discussions with private animal consortiums to utilize RadioGelT™2017-09-14T11:22:00Z<![CDATA[RICHLAND, Wash., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMI") (OTC PINK:ADMD), a late stage radiation oncology focused medical device company’s business plan is to generate initial revenues from animal therapy while pursuing FDA approval to use RadioGel™ for skin cancer in humans. The strategy is to prove the safety and effectiveness of the product via testing at four university veterinary hospitals.]]>https://www.globenewswire.com/news-release/2013/12/02/593766/10059925/en/Advanced-Medical-Isotope-Corporation-Announces-Three-Year-Business-Strategy-Focused-on-Transitioning-From-a-Development-Stage-Company-to-an-Operating-Company.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Corporation Announces Three Year Business Strategy Focused on Transitioning From a Development-Stage Company to an Operating Company2013-12-02T12:22:00Z<![CDATA[Operations to Center on Yttrium-90 Brachytherapy Products Following Anticipated Receipt of FDA Clearance of Y-90 RadioGel(TM) Brachytherapy Device KENNEWICK, Wash., Dec. 2, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that its Board of Directors has approved a three year business strategy focused on transitioning to full operations in 2014, following the anticipated receipt of FDA clearance for its patented brachytherapy cancer product, Yttrium-90 RadioGel]]>https://www.globenewswire.com/news-release/2013/11/15/590324/10058204/en/Advanced-Medical-Isotope-Corporation-to-Discuss-Third-Quarter-2013-Financial-Results-and-Provide-a-General-Business-Update.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Corporation to Discuss Third Quarter 2013 Financial Results and Provide a General Business Update2013-11-15T15:22:00Z<![CDATA[KENNEWICK, Wash., Nov. 15, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a general business update on November 18, 2013.]]>https://www.globenewswire.com/news-release/2013/11/07/587546/10056742/en/James-C-Katzaroff-CEO-Founder-of-Advanced-Medical-Isotope-Corporation-is-Featured-in-a-New-Audio-Interview-at-SmallCapVoice-com.html?f=22&fvtc=4&fvtv=5323James C. Katzaroff, CEO & Founder of Advanced Medical Isotope Corporation, is Featured in a New Audio Interview at SmallCapVoice.com2013-11-07T01:37:02Z<![CDATA[AUSTIN, Texas, Nov. 6, 2013 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. announced today that a new audio interview with ]]>https://www.globenewswire.com/news-release/2013/11/04/586042/10055867/en/Advanced-Medical-Isotope-Corporation-Files-510-k-Pre-Market-Notification-for-FDA-Clearance-of-Yttrium-90-RadioGel-TM-Brachytherapy-Product.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Corporation Files 510(k) Pre-Market Notification for FDA Clearance of Yttrium-90 RadioGel(TM) Brachytherapy Product2013-11-04T00:22:00Z<![CDATA[KENNEWICK, Wash., Nov. 3, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that it has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 RadioGel™ patented brachytherapy cancer product.]]>https://www.globenewswire.com/news-release/2013/10/11/579917/10051845/en/Kenin-M-Spivak-Elected-Vice-Chairman-of-Board-of-Directors-of-Advanced-Medical-Isotope-Corporation.html?f=22&fvtc=4&fvtv=5323Kenin M. Spivak Elected Vice Chairman of Board of Directors of Advanced Medical Isotope Corporation2013-10-11T13:30:33Z<![CDATA[KENNEWICK, Wash., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, today announced that Kenin M. Spivak has been elected to its board of directors as vice-chairman of the board. Concurrently, AMIC has modified and extended its consulting agreement with Spivak Management Inc. ("SMI").]]>https://www.globenewswire.com/news-release/2013/09/25/575877/10049957/en/Advanced-Medical-Isotope-Engages-Overton-Global-Partners.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Engages Overton Global Partners2013-09-25T16:41:34Z<![CDATA[KENNEWICK, Wash., Sept. 25, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCQB:ADMD), a company engaged in the production and distribution of medical isotopes, has recently signed an agreement with Overton Global Partners to introduce AMIC management to premier institutional fund managers and strategic partners in Europe.]]>https://www.globenewswire.com/news-release/2013/08/15/567264/10045210/en/UPDATE-Advanced-Medical-Isotope-Management-to-Discuss-Second-Quarter-2013-Financial-Results-and-Provide-a-Business-Update.html?f=22&fvtc=4&fvtv=5323UPDATE -- Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update2013-08-15T20:00:58Z<![CDATA[
KENNEWICK, Wash., Aug. 15, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.]]>https://www.globenewswire.com/news-release/2013/08/15/567249/10045199/en/Advanced-Medical-Isotope-Management-to-Discuss-Second-Quarter-2013-Financial-Results-and-Provide-a-Business-Update.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update2013-08-15T18:37:48Z<![CDATA[KENNEWICK, Wash., Aug. 15, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.]]>https://www.globenewswire.com/news-release/2013/08/13/566527/10044809/en/Advanced-Medical-Isotope-Management-to-Give-Update.html?f=22&fvtc=4&fvtv=5323Advanced Medical Isotope Management to Give Update2013-08-13T15:26:40Z<![CDATA[KENNEWICK, Wash., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will hold an investor call at 10 am pacific on Tuesday, August 13. Call in number is 800.839.9416 and pin is 1318768.]]>